S
Shin Kawamata
Researcher at Foundation for Biomedical Research
Publications - 63
Citations - 3400
Shin Kawamata is an academic researcher from Foundation for Biomedical Research. The author has contributed to research in topics: Induced pluripotent stem cell & Embryonic stem cell. The author has an hindex of 25, co-authored 57 publications receiving 2763 citations. Previous affiliations of Shin Kawamata include Toyota.
Papers
More filters
Journal ArticleDOI
Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration
Michiko Mandai,Akira Watanabe,Yasuo Kurimoto,Yasuhiko Hirami,Chikako Morinaga,Takashi Daimon,Masashi Fujihara,Hiroshi Akimaru,Noriko Sakai,Yumiko Shibata,Motoki Terada,Yui Nomiya,Shigeki Tanishima,Masahiro Nakamura,Hiroyuki Kamao,Sunao Sugita,Akishi Onishi,Tomoko Ito,Kanako Fujita,Shin Kawamata,Masahiro J. Go,Chikara Shinohara,Kenichiro Hata,Masanori Sawada,Midori Yamamoto,Sachiko Ohta,Yasuo Ohara,Kenichi Yoshida,Junko Kuwahara,Yuko Kitano,Naoki Amano,Masafumi Umekage,Fumiyo Kitaoka,Azusa Tanaka,Chihiro Okada,Naoko Takasu,Seishi Ogawa,Shinya Yamanaka,Masayo Takahashi +38 more
TL;DR: At 1 year after surgery, the transplanted sheet of retinal pigment epithelial cells remained intact, best corrected visual acuity had not improved or worsened, and cystoid macular edema was present.
Journal ArticleDOI
Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors
Hiroshi Ban,Naoki Nishishita,Noemi Fusaki,Toshiaki Tabata,Koichi Saeki,Masayuki Shikamura,Nozomi Takada,Makoto Inoue,Mamoru Hasegawa,Shin Kawamata,Shin-Ichi Nishikawa +10 more
TL;DR: It is shown that Sendai virus vector, an RNA virus vector that carries no risk of integrating into the host genome, is a practical solution for the efficient generation of safer iPSCs and suggested that generation of transgene-free iPSCS from cord blood cells should be an important step in providing allogeneic iPSC-derived therapy in the future.
Journal ArticleDOI
Tumorigenicity studies of induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) for the treatment of age-related macular degeneration.
Hoshimi Kanemura,Masahiro J. Go,Masayuki Shikamura,Naoki Nishishita,Noriko Sakai,Hiroyuki Kamao,Michiko Mandai,Chikako Morinaga,Masayo Takahashi,Shin Kawamata +9 more
TL;DR: The tumorigenic potential of induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) for the treatment of wet-type, age-related macular degeneration (AMD) is reported and it is concluded that the iPSC-derived RPE was negligible.
Journal ArticleDOI
Highly Sensitive In Vitro Methods for Detection of Residual Undifferentiated Cells in Retinal Pigment Epithelial Cells Derived from Human iPS Cells
Takuya Kuroda,Satoshi Yasuda,Shinji Kusakawa,Naoya Hirata,Yasunari Kanda,Kazuhiro Suzuki,Masayo Takahashi,Shin-Ichi Nishikawa,Shin Kawamata,Yoji Sato,Yoji Sato +10 more
TL;DR: Three in vitro assay methods to detect undifferentiated hiPSCs are examined, providing highly sensitive and quantitative in vitro assays essential for facilitating safety profiling of hiPSC-derived products for future regenerative medicine research.
Journal ArticleDOI
Quality control guidelines for clinical-grade human induced pluripotent stem cell lines.
Stephen R. Sullivan,Glyn Stacey,Chihiro Akazawa,Naoki Aoyama,Ricardo P. Baptista,Patrick Bedford,Annelise Bennaceur Griscelli,Amit Chandra,Ngaire Elwood,Mathilde Girard,Shin Kawamata,Tadaaki Hanatani,Theodoros Latsis,Stephen Lin,Tenneille Ludwig,Tamara Malygina,Amanda Mack,Joanne C. Mountford,Scott Noggle,Lygia da Veiga Pereira,Jack Price,Michael Sheldon,Alok Srivastava,Harald Stachelscheid,Shaji R Velayudhan,Natalie J Ward,Marc L Turner,Marc L Turner,Marc L Turner,Jacqueline Barry,Jacqueline Barry,Jihwan Song +31 more
TL;DR: Initial recommendations on the minimum dataset required to consider an iPSC line of clinical grade are outlined in this report, which are likely to lead to revision of these guidelines on a regular basis.